scispace - formally typeset
J

John M. Pawelek

Researcher at Yale University

Publications -  155
Citations -  15099

John M. Pawelek is an academic researcher from Yale University. The author has contributed to research in topics: Melanin & Melanoma. The author has an hindex of 57, co-authored 155 publications receiving 13516 citations. Previous affiliations of John M. Pawelek include Loyola University Medical Center & New York University.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal Article

Tumor-targeted Salmonella as a novel anticancer vector.

TL;DR: It is demonstrated that genetically engineered Salmonella have many of the desirable properties of a delivery vector, including targeting of multiple tumors from a distant inoculation site, selective replication within tumors, tumor retardation, and the ability to express effector genes, such as the herpes simplex virus thymidine kinase (HSV TK).
Journal ArticleDOI

Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin

TL;DR: Tyrosinase, purified from murine melanomas and the skins of brown mice, has now been shown to catalyze a third reaction in mammalian melanogenesis, namely the conversion of 5,6-dihydroxyindile to melanochrome.
Journal ArticleDOI

Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo

TL;DR: It is reported here that disruption of the Salmonella msbB gene reduces TNFα induction and increases the LD50 of this pathogenic bacteria by 10,000-fold and suggests that the antitumor activity of these bacteria may be independent of TNF α.
Journal ArticleDOI

Targeting ER stress–induced autophagy overcomes BRAF inhibitor resistance in melanoma

TL;DR: Using tumor biopsies from BRAF(V600E) melanoma patients treated either with BRAFi or with combined BRAF and MEK inhibition, it is found that BRAFi-resistant tumors had increased levels of autophagy compared with baseline and a rationale for combination approaches targeting this resistance pathway is provided.